Sridhar, Devi Lalita.
Devi Sridhar chercheuse américaine en santé publique
Sridhar, Devi
Sridhar, Devi Lalita 1984-
Sridhar, Devi (Devi Lalita)
VIAF ID: 31963888 (Personal)
Permalink: http://viaf.org/viaf/31963888
Preferred Forms
- 100 0 _ ‡a Devi Sridhar ‡c chercheuse américaine en santé publique
- 200 _ | ‡a Sridhar ‡b Devi
-
-
- 100 1 _ ‡a Sridhar, Devi Lalita
- 100 1 _ ‡a Sridhar, Devi Lalita
- 100 1 _ ‡a Sridhar, Devi Lalita
-
- 100 1 _ ‡a Sridhar, Devi Lalita
-
-
- 100 1 _ ‡a Sridhar, Devi Lalita ‡d 1984-
-
-
4xx's: Alternate Name Forms (7)
5xx's: Related Names (3)
- 510 2 _ ‡a All Souls College ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Oxford University ‡b School of Government ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a School of Social and Political Science ‡g Edinburgh ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Anthropologists inside organisations : South Asian case studies | |
The art of the Bank, 2006: | |
The battle against hunger : choice, circumstance, and the World Bank | |
Challenges in tracking global malaria spending | |
Coordinating the UN System: lessons from UNAIDS: a commentary on Mackey | |
COVID-19 Futures: A Framework for Exploring Medium and Long-Term Impacts | |
COVID-19 in Germany and China: mitigation versus elimination strategy | |
Covid-19: Keeping schools as safe as possible | |
COVID-19: what health experts could and could not predict | |
Evidence informing the UK's COVID-19 public health response must be transparent | |
The extricable links between health, wealth, and profits | |
Facing forward after Ebola: questions for the next director general of the World Health Organization | |
Firearm injury—a preventable public health issue | |
Global health funding: how much, where it comes from and where it goes | |
Global health governance in the sustainable development goals: Is it grounded in the right to health? | |
Global health security and universal health coverage: from a marriage of convenience to a strategic, effective partnership | |
Global rules for global health: why we need an independent, impartial WHO. | |
Governing global health : who runs the world and why? | |
Government responses and COVID-19 deaths: Global evidence across multiple pandemic waves | |
The growing human footprint on the planet. | |
Health as a "global public good": creating a market for pandemic risk. | |
Health financing in Brazil, Russia and India: what role does the international community play? | |
Health policy: from the clinical to the economic gaze | |
Health policy: Regulate alcohol for global health | |
Herd immunity by infection is not an option | |
UN High-Level Meeting on antimicrobials--what do we need? | |
Hindsight is 2020? Lessons in global health governance one year into the pandemic | |
Holding a mirror up to global health | |
How can we improve self-isolation and quarantine for covid-19? | |
How to do (or not to do) ... Tracking data on development assistance for health | |
Improving Access to Essential Medicines: How Health Concerns can be Prioritised in the Global Governance System | |
Improving aid for maternal, newborn, and child health | |
Improving health aid for a better planet: The planning, monitoring and evaluation tool (PLANET). | |
Introduction: Analysing global health assistance: the reach for ethnographic, institutional and political economic scope | |
The Joint Action and learning initiative: towards a global agreement on national and global responsibilities for health | |
Lancet Commission on synergies between universal health coverage, health security, and health promotion | |
Lessons from Leicester: a covid-19 testing system that's not fit for purpose | |
Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe | |
Mainstreaming as rhetoric or reality? Gender and global health at the World Bank | |
Making the SDGs useful: a Herculean task | |
Measuring the global response to antimicrobial resistance, 2020–21: a systematic governance analysis of 114 countries | |
Metric partnerships: global burden of disease estimates within the World Bank, the World Health Organisation and the Institute for Health Metrics and Evaluation | |
Minimise, manage, and modify: the UK must create and use time | |
Misfinancing global health: a case for transparency in disbursements and decision making | |
Off the back burner: diverse and gender-inclusive decision-making for COVID-19 response and recovery | |
The pandemic legacy of antimicrobial resistance in the USA | |
Pneumonia: a global cause without champions | |
Polio: from eradication to systematic, sustained control | |
Population: Better lives, not just contraceptives. | |
Post-Ebola reforms: ample analysis, inadequate action | |
Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis | |
Preventable : how a pandemic changed the world & how to stop the next one | |
Reconsider this summer’s Olympic and Paralympic games | |
RESPIRE: The National Institute for Health Research's (NIHR) Global Respiratory Health Unit | |
Response to reviews | |
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties | |
SARS-CoV-2 variants and ending the COVID-19 pandemic | |
Scientific consensus on the COVID-19 pandemic: we need to act now | |
Setting health research priorities using the CHNRI method: VII. A review of the first 50 applications of the CHNRI method | |
Seven Challenges in International Development Assistance for Health and Ways Forward | |
The social sciences, humanities, and health | |
Staying sane in our new COVID-19 world | |
Structure, function and five basic needs of the global health research system | |
Towards a framework convention on global health | |
Transparency assessment of COVID-19 models | |
Trojan Multilateralism: Global Cooperation in Health | |
Universal Health Coverage and the Right to Health: From Legal Principle to Post-2015 Indicators. | |
Universal health coverage, health systems strengthening, and the World Bank. | |
Urbanization and prevalence of type 2 diabetes in Southern Asia: A systematic analysis. | |
US decision to pull out of World Health Organization | |
We should learn from the Asia–Pacific responses to COVID-19 | |
What's the way out? Potential exit strategies from the COVID-19 lockdown | |
Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance | |
Who sets the global health research agenda? The challenge of multi-bi financing | |
Why Scotland's slow and steady approach to covid-19 is working | |
Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola | |
The World Bank & financing tuberculosis control, 1986-2017 | |
The World Bank reinvents itself – and puts poverty reduction at risk | |
World Bank's financing, priorities, and lending structures for global health | |
Youth manifesto on non-communicable diseases |